Back to search
FDAFDA · Food and drugs·Recall number Z-1201-2025

remel BLOOD AGAR EMB AGAR BIPLATE, REF R02041, QTY 100, for invitro diagnostic use

Published February 26, 2025 · Recall initiated: February 13, 2025

Summary

FDA records medical device Class II recall Z-1201-2025, published February 26, 2025 and initiated February 13, 2025. Recalling firm: Remel, Inc; Status: Ongoing; Reported quantity: 316 units; Lot: UDI/DI 848838003684, Lot Number 213971, exp. 2025-02-25. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Product may contain surface and subsurface contamination of Listeria monocytogenes which is typically visible immediately upon removal from the packaging, appearing on the blood side of the biplate.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Remel, Inc
Distributor
US Nationwide distribution.
Lot
UDI/DI 848838003684, Lot Number 213971, exp. 2025-02-25
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was remel BLOOD AGAR EMB AGAR BIPLATE, REF R02041, QTY 100, for invitro diagnostic use recalled?

Yes. FDA published recall Z-1201-2025 on February 26, 2025. Reported hazard: Product may contain surface and subsurface contamination of Listeria monocytogenes which is typically visible immediately upon removal from the packaging, appearing on the blood side of the biplate.

What should I do if I have this product?

Voluntary: Firm initiated · Letter